SEC Form 4 · accession 0001209191-16-142359
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jayant Aphale
Officer — VP, Technical Operations
Period of report
Sep 19, 2016
Accepted (ET)
Sep 21, 2016 · 9:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 19, 2016 | M | 10,000 | $4.62 | A | 21,490 | D | |
| Common StockF1 | Sep 19, 2016 | S | 10,000 | $50.00 | D | 11,490 | D | |
| Common StockF1 | Sep 19, 2016 | M | 25,000 | $4.62 | A | 36,490 | D | |
| Common StockF1 | Sep 19, 2016 | S | 25,000 | $50.00 | D | 11,490 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Options (right to buy)F1 | $4.62 | Sep 19, 2016 | M | 10,000 | D | Dec 22, 2012 | Dec 22, 2021 | Common Stock | 10,000 | 3,420 | D |
| Incentive Stock Options (right to buy) | $4.62 | Sep 19, 2016 | M | 25,000 | D | Dec 22, 2012 | Dec 22, 2021 | Common Stock | 25,000 | 61,580 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on December 11, 2015, accordingly, the reporting person had no discretion with regards to the timing of the transaction.